prof. MUDr. Tomáš Büchler, Ph.D.
Total number of publications: 88
2011
-
Nádorové markery
Obecná onkologie, edition: Vyd. 1., year: 2011, number of pages: 7 s.
-
Similar efficacy of thalidomide- and bortezomib-based regimens for first relapse of multiple myeloma
Annals of hematology, year: 2011, volume: 90, edition: 12, DOI
-
Výsledky terapie metastatického renálního karcinomu lékem everolimus – analýza údajů z klinického registru RENIS
Klinická onkologie, year: 2011, volume: 24, edition: 5
2010
-
Antiangiogenní léčba metastatického kolorektálního karcinomu - analýza dat z dvou center
Onkologie, Olomouc, Solen., year: 2010, volume: vol. 4, edition: no. 3
-
Gain of 1q21 Is an Unfavorable Genetic Prognostic Factor for Multiple Myeloma Patients Treated with High-Dose Chemotherapy
Biology of Blood and Marrow Transplantation, year: 2010, volume: 16, edition: 4
-
Generation of myeloma-specific T cells using dendritic cells loaded with MUC1- and hTERT- drived nonapeptides or myeloma cell apoptotic bodies
Neoplasma, year: 2010, volume: 57, edition: 5
-
IgA pemphigus associated with monoclonal gammopathy completely resolved after achievement of complete remission of multiple myeloma with bortezomib, cyclophosphamide and dexamethasone regimen
Wiener klinische Wochenschrift, year: 2010, volume: 122, edition: 9-10
-
Levels of angiogenic factors in patients with multiple myeloma correlate with treatment response
Annals of Hematology, year: 2010, volume: 89, edition: 4
-
Mezilaboratorní studie stanovení volných monoklonálních lehkých řetězců imunoglobulinů
Klinická biochemie a matabolismus, year: 2010, volume: 18, edition: 2
-
Negative prognostic significance of two or more cytogenetic abnormalities in multiple myeloma patients treated with autologous stem cell transplantation
Neoplasma, year: 2010, volume: 57, edition: 2